Algorhythm Holdings
RIME
8 hedge funds and large institutions have $726K invested in Algorhythm Holdings in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
64% more capital invested
Capital invested by funds: $442K → $726K (+$284K)
14% more funds holding
Funds holding: 7 → 8 (+1)
0.01% more ownership
Funds ownership: 0.01% → 0.03% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$371K |
| 2 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$62.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$15.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.36K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$1.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2K |
RIME Hedge Fund Activity: Q4 2022 in Review
8 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Algorhythm Holdings (RIME) for Q4 2022, worth a combined $726K — up 64% from $442K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RIME positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Perritt Capital Management, adding an estimated $371K. The largest seller was Morgan Stanley, exiting entirely with an estimated $2K sold.
- 8 institutional investors held Algorhythm Holdings (RIME) as of Q4 2022, up from 7 in Q3 2022.
- Funds reported $726K of Algorhythm Holdings stock for Q4 2022, up 64% quarter-over-quarter.
- 2 funds opened new Algorhythm Holdings positions in Q4 2022 and 1 closed out, a net change of +1 holder.
- The largest Algorhythm Holdings buyer in Q4 2022 was Perritt Capital Management, an estimated $371K added.
- The largest Algorhythm Holdings seller in Q4 2022 was Morgan Stanley, an estimated $2K sold.
Based on aggregated 13F filings for Q4 2022.